Suchbegriffe: REAL-WORLD ANALYSIS, . Treffer: 3
Prager, GW; Oehler, L; Gerger, A; Mlineritsch, B; Andel, J; Petzer, A; Wilthoner, K; Sliwa, T; Pichler, P; Winder, T; Heibl, S; Gruenberger, B; Laengle, F; Hubmann, E; Korger, M; Pecherstorfer, M; Djanani, A; Neumann, HJ; Philipp-Abbrederis, K; Wöll, E; Trondl, R; Arnold-Schrauf, C; Eisterer, W
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer. 2021; 143:101-112
Doi: 10.1016/j.ejca.2020.11.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T
Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Wien Klin Wochenschr. 2021; 133(1-2):21-25
Doi: 10.1007/s00508-019-01556-1
Web of Science
PubMed
FullText
FullText_MUG
Rojo, F; Corassa, M; Mavroudis, D; Öz, AB; Biesma, B; Brcic, L; Pauwels, P; Sailer, V; Gosney, J; Miljkovic, D; Hader, C; Wu, M; Almarez, T; Penault-Llorca, F
International real-world study of DLL3 expression in patients with small cell lung cancer.
Lung Cancer. 2020; 147:237-243
Doi: 10.1016/j.lungcan.2020.07.026
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG